News Briefs: September 16, 2019

Black Market Leading Cali Cannabis Sales

This past week, per the Los Angeles Times, the United Cannabis Business Association (UCBA) turned in the findings of an audit on illicit and legal operating cannabis stores to Gov. Gavin Newsom (D- Calif.) that was gathered with the aid of online website WeedMaps. The audit showed that there were 3,757 listings for a marijuana dispensary or cannabis delivery service in California… which is a problem given that only 873 cannabis sellers are licensed in the state. By the UCBA’s estimates, 2,835 of the 3,757 listings on WeedMaps are for unlicensed sellers. Put another way, there are more than three times as many illegal retailers than there are legal dispensaries or delivery services.

Read more

 

New Bill on the Table to Reschedule Marjuana

Rep. Greg Steube (R-FL) introduced the legislation, which is titled the “Marijuana 1-to-3 Act.” True to its name, the bill would simply require the attorney general to move cannabis from Schedule I to Schedule III under the Controlled Substances Act, with the aim of increasing research on the drug’s effects.

Read More

 

Feds Want Lots of Drugs

The Drug Enforcement Administration (DEA) wants 3,200,000 grams of marijuana to be legally grown in the U.S. next year, the agency announced. The more than 7,000 pounds of cannabis will be used in scientific studies investigating the effects of the plant. Separately in the new Federal Register notice, DEA is proposing that 384,460 grams of tetrahydrocannabinols, 40 grams of LSD, 50 grams of MDMA and 30 grams of psilocybin be produced next year.

Read More

 

Is Google Banning CBD Ads?

Google has announced a new policy for speculative and experimental medicines. In its section concerning advertisements, Google shared its new “Healthcare and Medicines” policy.

The new policy prohibits, “advertising for unproven or experimental medical techniques such as most stem cell therapy, cellular (non-stem) therapy, and gene therapy.”

The policy does not explicitly identify CBD, but it does lead to the question as to whether these substances will be excluded under the new policy. After all, at the end of the day, the benefits of CBD is largely dependent upon anecdotal, and not clinical evidence.

Read More

 

Juul Thumbs Nose at FDA

The FDA is hot on the trail of Juul about an ad campaign from the vaping company that recommended consumers switch from regular cigarettes. Is Juul worried? Nah. A company spokesman told CNBC that Juul plans to continue running the commercials and has already bought ads for the next month.

Read More

Facebook
Twitter
Pinterest
Print
Email

Recent Articles

How to Prepare for Holiday Shoppers

Holiday shopping is an early-bird game. The first place a shopper sees a deal and decides to buy it — guess what? That’s a product they’re not buying from the competition. Today’s consumers are searching for the best deals and most unique gifts, but gone are the days of customers idly wandering the neighborhood or

Read More »

Who’s Your Best Customer?

The tides are shifting in regards to cannabis usage with the majority of cannabis consumers—roughly three-quarters—partaking five or more times per week. That’s your golden opportunity to appeal to that customer segment through product variety and affordability.   According to a report from the Brightfield Group, a Chicago-based market research firm focused on the cannabis

Read More »

Lifestyle Brand Consumers Put a Premium on Sustainability

A growing percentage of consumers care more about the sustainable practices of the brands with which they engage. In a recent survey by Stifel and Morning Consult, more than half of the survey’s respondents shared they had bought from a new brand specifically for its transparent, environmentally responsive, and sustainable practice. Similarly to how high-end

Read More »

Injunctions Sought Against E-cig Manufacturers as FDA Steps Up Enforcement

The US Department of Justice has taken legal action against six e-cigarette manufacturers on behalf of the US Food and Drug Administration.  Morin Enterprises Inc. (doing business as E-Cig Crib), Soul Vapor, Super Vape’z, Vapor Craft, Lucky’s Convenience & Tobacco, and Seditious Vapours failed to submit the necessary premarket applications for their e-cigarette products “and

Read More »

Realize Live Resin Blood Orange OG Kush Gummies

There are so many Delta 9 gummies on the market that it can be difficult to pick a winner — unless you go with Realize (formerly Pow Pow) brand Live Resin, Blood Orange Kush gummies that took the top spot in the edibles: gummies category at the 2022 High Times Cannabis Cup. With many worthy

Read More »

Social Media

Most Recent

Are you 18 or older?